Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC

Clinical trial NCT01259193 · UNKNOWN

Trial details

NCT number: NCT01259193
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2010-10-01
Primary completion: 2011-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.